跳至主要内容
临床试验/NCT03891654
NCT03891654已完成早期 1 期

Pilot Study of Dynamic Contrast Enhanced Computed Tomography (DCE-CT) Imaging for the Assessment of Radiation Therapy Outcome for Liver Cancer Patients

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
3
试验地点
2
主要终点
DCE-CT Perfusion Metrics: Blood Volume

研究概览

简要总结

This is a pilot study that uses a standard of care technique, Stereotactic Body Radiation Therapy (SBRT), in combination with Dynamic Contrast Enhanced Computed Tomography (DCE-CT) to determine if perfusion changes from SBRT of liver cancer may be used for outcome assessment and prediction of prognosis.

详细描述

Patients will undergo standard of care SBRT while also receiving DCE-CT, also known as perfusion CT, pre-treatment, 6 hours post-treatment and 6 weeks post-treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision to sign and date the consent form
  • Stated willingness to comply with all study procedures and be available for the duration of the study
  • Be a Male or Female aged 18-100
  • Diagnosed with Liver HCC or metastases
  • Must be receiving or will plan to receive SBRT for Liver HCC or metastases

排除标准

  • Allergy to iodine contrast
  • CT with contrast not offered as a Standard of Care
  • Pregnant women

结局指标

主要结局

DCE-CT Perfusion Metrics: Blood Volume

时间窗: Baseline to end of follow-up, up to 12 weeks

Determine the association between the delivered radiation therapy dose distribution and the change in perfusion measurement through blood volume as shown through DCE-CT imaging.

DCE-CT Perfusion Metrics: K-Trans

时间窗: Baseline to end of follow-up, up to 12 weeks

Determine the association between the delivered radiation therapy dose distribution and the change in perfusion measurement through K-Trans (extraction-flow product) as shown through DCE-CT imaging.

DCE-CT Perfusion Metrics: Blood Flow

时间窗: Baseline to end of follow-up, up to 12 weeks

Determine the association between the delivered radiation therapy dose distribution and the change in perfusion measurement through blood flow as shown through DCE-CT imaging.

次要结局

  • Correlation Between Patient Demographics and Blood Volume: Age(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Flow: Sex(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and K-Trans: Sex(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and K-Trans: Age(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and K-Trans: Clinical Stage of Disease(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and K-Trans: Race(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Volume: Sex(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Volume: Clinical Stage of Disease(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Flow: Age(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Flow: Race(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Volume: Race(Post follow-up to end of study, up to 12 months)
  • Correlation Between Patient Demographics and Blood Flow: Clinical Stage of Disease(Post follow-up to end of study, up to 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
1 期
SBRT Pre-operatively for Pancreatic CancerPancreatic Neoplasms
NCT02308722University of Oxford12
终止
不适用
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck CancerRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharyngeal Keratinizing Squamous Cell CarcinomaRecurrent Oral Cavity Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell CarcinomaStage II Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell CarcinomaStage III Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaStage III Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage III Oral Cavity Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell CarcinomaStage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Hypopharyngeal Squamous Cell CarcinomaStage IVB Laryngeal Squamous Cell CarcinomaStage IVB Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage IVB Oral Cavity Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell CarcinomaStage IVC Hypopharyngeal Squamous Cell CarcinomaStage IVC Laryngeal Squamous Cell CarcinomaStage IVC Nasopharyngeal Keratinizing Squamous Cell CarcinomaStage IVC Oral Cavity Squamous Cell CarcinomaStage IVC Oropharyngeal Squamous Cell Carcinoma
NCT02388932Case Comprehensive Cancer Center3
进行中(未招募)
不适用
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate CancerCancer of the ProstateProstate Cancer
NCT05628363Washington University School of Medicine28
已完成
不适用
Stereotactic Body Radiation Therapy (SBRT) for Liver MetsLiver Metastases
NCT01360606Susannah Ellsworth9
终止
不适用
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney CancerMetastatic Renal Cell CancerRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
NCT02542202University of Chicago25